US pauses J&J vaccine in blow to global immunization drive

US health authorities on Tuesday recommended pausing the Johnson & Johnson COVID shot over blood clot fears, with the company quickly announcing it would delay its European rollout, in a setback for global immunization campaigns.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

The information on this site is of a general nature only and is not intended to address the specific circumstances of any particular individual or entity. It is not intended or implied to be a substitute for professional advice. Read more.